Search research articles
Contact Us
Filters
Showing results (51-60 of 85) with videos related to
Page
of 9
Sort By:
European Journal of Haematology
|
September 30, 2018
Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials
Pere Barba, Mireia Morgades, Pau Montesinos, et al.
Hemasphere
|
July 21, 2023
Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia
Alberto Alvarez-Larrán, Beatriz Cuevas, Patricia Velez, et al.
The Lancet. Haematology
|
July 30, 2023
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study
Aaron T Gerds, Srdan Verstovsek, Alessandro M Vannucchi, et al.
Leukemia
|
September 28, 2024
Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia
Marta Santaliestra, Marta Garrote, María Soledad Noya, et al.
Leukemia
|
June 3, 2021
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
Per Ljungman, Rafael de la Camara, Malgorzata Mikulska, et al.
Medicina Clinica
|
January 26, 2020
Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis
Irene Pastor-Galán, Juan Carlos Hernández-Boluda, Juan-Gonzalo Correa, et al.
British Journal of Haematology
|
August 12, 2025
Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH-TC study
Carles Tolosa-Ridao, Mónica Baile González, Marina Acera Gómez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 28, 2020
Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model
Juan-Carlos Hernández-Boluda, Arturo Pereira, Alberto Alvarez-Larran, et al.
Frontiers in Immunology
|
January 22, 2025
Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care
María Queralt Salas, María Teresa Solano, Mónica Baile González, et al.
Hemasphere
|
April 6, 2026
Response to therapy and prognosis according to molecular characterization in <i>CALR</i>-mutated essential thrombocythemia
Marta Santaliestra, Marta Garrote, María Concepción Fernández-Rodríguez, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 85) with videos related to
Sort By:
Page
of 9
European Journal of Haematology
|
September 30, 2018
Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials
Pere Barba, Mireia Morgades, Pau Montesinos, et al.
Hemasphere
|
July 21, 2023
Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia
Alberto Alvarez-Larrán, Beatriz Cuevas, Patricia Velez, et al.
The Lancet. Haematology
|
July 30, 2023
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study
Aaron T Gerds, Srdan Verstovsek, Alessandro M Vannucchi, et al.
Leukemia
|
September 28, 2024
Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia
Marta Santaliestra, Marta Garrote, María Soledad Noya, et al.
Leukemia
|
June 3, 2021
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
Per Ljungman, Rafael de la Camara, Malgorzata Mikulska, et al.
Medicina Clinica
|
January 26, 2020
Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis
Irene Pastor-Galán, Juan Carlos Hernández-Boluda, Juan-Gonzalo Correa, et al.
British Journal of Haematology
|
August 12, 2025
Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH-TC study
Carles Tolosa-Ridao, Mónica Baile González, Marina Acera Gómez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 28, 2020
Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model
Juan-Carlos Hernández-Boluda, Arturo Pereira, Alberto Alvarez-Larran, et al.
Frontiers in Immunology
|
January 22, 2025
Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care
María Queralt Salas, María Teresa Solano, Mónica Baile González, et al.
Hemasphere
|
April 6, 2026
Response to therapy and prognosis according to molecular characterization in <i>CALR</i>-mutated essential thrombocythemia
Marta Santaliestra, Marta Garrote, María Concepción Fernández-Rodríguez, et al.
Page
of 9